These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 26113905)
1. [Change in stature after pseudo-puberty early by 11ß hydroxylase deficiency in a girl of 7 years: report of a case and review of literature]. Latrech H; Gaouzi A Pan Afr Med J; 2015; 20():162. PubMed ID: 26113905 [TBL] [Abstract][Full Text] [Related]
3. LHRH analog treatment of central precocious puberty complicating congenital adrenal hyperplasia. Pescovitz OH; Cassorla F; Comite F; Loriaux DL; Cutler GB Ann N Y Acad Sci; 1985; 458():174-81. PubMed ID: 3911847 [No Abstract] [Full Text] [Related]
4. [Pseudo- and central precocious puberty due to adrenogenital syndrome]. Pouw IS; Drop SL; Ladée-Levy JV; Slijper FM Tijdschr Kindergeneeskd; 1986 Jun; 54(3):77-83. PubMed ID: 2944246 [TBL] [Abstract][Full Text] [Related]
5. [Precocious puberty in a girl with congenital adrenal hyperplasia following the initiation of hydrocortisone replacement therapy (author's transl)]. Dumić M; Radica A; Tajić M; Crnojević-Ivanusić R Lijec Vjesn; 1981 Jun; 103(6):242-4. PubMed ID: 7321748 [No Abstract] [Full Text] [Related]
6. Boy with central precocious puberty probably due to a peripheral cause. Sahana PK; Gopal Sankar KS; Sengupta N; Chattopadhyay K BMJ Case Rep; 2016 Jun; 2016():. PubMed ID: 27256994 [TBL] [Abstract][Full Text] [Related]
7. Prolongation of growth by treatment of 11-hydroxylase deficiency with depot-leuprolide, growth hormone, and hydrocortisone. Chalmers LJ; Casas L; New MI; Blackett PR J Pediatr Endocrinol Metab; 2006 Oct; 19(10):1251-5. PubMed ID: 17172087 [TBL] [Abstract][Full Text] [Related]
9. Growth and pubertal development in patients with congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency. Hochberg Z; Schechter J; Benderly A; Leiberman E; Rosler A Am J Dis Child; 1985 Aug; 139(8):771-6. PubMed ID: 3875277 [TBL] [Abstract][Full Text] [Related]
10. [Diagnosis of steroid-11-beta hydroxylase deficiency]. Sólyom J; Cholnoky P; Helmuth D; Dietrich K; Nagy E; Varga I; Gláz E Orv Hetil; 1986 Sep; 127(36):2171-5. PubMed ID: 3463925 [No Abstract] [Full Text] [Related]
11. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty. Boepple PA; Mansfield MJ; Wierman ME; Rudlin CR; Bode HH; Crigler JF; Crawford JD; Crowley WF Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629 [TBL] [Abstract][Full Text] [Related]
12. The effects of gonadotropin releasing hormone analogue therapy on girls with gonadotropin-dependent precocious puberty. Tung YC; Lee JS; Tsai WY; Hsiao PH J Formos Med Assoc; 2007 Oct; 106(10):826-31. PubMed ID: 17964961 [TBL] [Abstract][Full Text] [Related]
13. [Congenital virilizing adrenal hyperplasia due to 11 -beta-hydroxylase deficiency. Study of 11 cases (author's transl)]. Dunand A; Roger M; Chaussain JL; Nocton F; Job JC Ann Pediatr (Paris); 1981 Mar; 28(3):179-84. PubMed ID: 7224566 [No Abstract] [Full Text] [Related]
14. Peripheral precocious puberty with hypertension. Reddy S; Rao M; Rao MN Indian Pediatr; 1992 Jan; 29(1):109-11. PubMed ID: 1601479 [No Abstract] [Full Text] [Related]
15. [The use of cyproteronacetate in patients with adrenogenital syndrome caused by C-21 hydroxylase deficiency]. Tóth S; Faredin I; Soltysiak J; László F Orv Hetil; 1974 Oct; 115(42):2487-90. PubMed ID: 4417366 [No Abstract] [Full Text] [Related]
16. Hyperandrogenism in a child with multiple endocrine neoplasia type 1. García García E; Mangas Cruz MÁ; Guerrero Vázquez R; Navarro González E Endocrinol Diabetes Nutr (Engl Ed); 2019 Feb; 66(2):132-133. PubMed ID: 30591325 [No Abstract] [Full Text] [Related]